LMYC antibody (AA 1-206)
Quick Overview for LMYC antibody (AA 1-206) (ABIN2311168)
Target
See all LMYC (MYCL) AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- AA 1-206
- 
                                            Cross-Reactivity
- Human
- 
                                            Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
- 
                                            Characteristics
- MYCL (MYCL1, v-Myc Myelocytomatosis Viral Oncogene Homolog 1 Lung Carcinoma Derived (Avian), Class E Basic Helix-loop-helix Protein 38, bHLHe38, LMYC, L-Myc, L-myc-1 Proto-oncogene Protein)
- 
                                            Purification
- Purified by Protein A affinity chromatography.
- 
                                            Immunogen
- Full length human MYCL1, aa1-206 (NP_005367.1).
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- Optimal working conditions should be determined by the investigator.
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- Supplied as a liquid in PBS, pH 7.2.
- 
                                            Storage
- -20 °C
- 
                                            Storage Comment
- -20°C
 
- 
                                            
- 
    - LMYC (MYCL) (Protein L-Myc (MYCL))
- 
                                            Alternative Name
- MYCL
- 
                                            NCBI Accession
- NM_005376, NP_005367
- 
                                            Pathways
- Warburg Effect
 Target
- 
                    
 
                                     
                                     
                                    